Blood collection in Beirut, Lebanon. © SRK, Monika Flückiger Greiner Bio-One is supporting a Swiss Red Cross (SRK) project to modernise the blood donor service and the provision of safe blood supplies for Syrian refugees and the wider public in Lebanon. Kremsmünster, August 2019. Greiner Bio-One has been a project partner of the Swiss Red... Read more
Observations from a ZEISS executive leader on one of the largest microscopy conferences in the world Events The annual Microscopy & Microanalysis (M&M) conference was recently held in Portland, Oregon, USA. ZEISS is one of the largest sponsors and exhibitors at this meeting for the Microscopy Society of America that is dedicated to the promotion... Read more
Observations from a ZEISS executive leader on one of the largest microscopy conferences in the world The annual Microscopy & Microanalysis (M&M) conference was recently held in Portland, Oregon, USA. ZEISS is one of the largest sponsors and exhibitors at this meeting for the Microscopy Society of America that is dedicated to the promotion and... Read more
AUGUST 13, 2019 WALTHAM, MA Redesign Reflects Expanded Technologies, Brands and Capabilities with Improved Navigation Excelitas Technologies® Corp., a global technology leader delivering innovative, off-the-shelf and customized photonic solutions, has launched a new corporate website at www.excelitas.com. The new website provides a comprehensive and informative resource highlighting Excelitas’ diverse range of product and technology offerings, expert custom engineering and manufacturing... Read more
Basel, 05 August 2019 Roche’s Tecentriq plus platinum-based chemotherapy reduced the risk of disease worsening or death in people with previously untreated advanced bladder cancer IMvigor130 is the first positive Phase III study of a cancer immunotherapy combination in previously untreated advanced bladder cancer Data will be shared with health authorities globally, including the U.S.... Read more
EDEN PRAIRIE, Minn., July 30, 2019 /PRNewswire/ — MTS Systems Corporation (Nasdaq: MTSC), a leading global supplier of high performance test systems, motion simulators and sensors, today announced that its Board of Directors has declared a quarterly dividend of $0.30 per share. The dividend is payable on September 30, 2019 to shareholders of record as of the... Read more
EDEN PRAIRIE, Minn., July 29, 2019 /PRNewswire/ — MTS Systems Corporation (NASDAQ: MTSC), a leading global supplier of high-performance test systems, motion simulators and sensors, today announced award of a contract valued at $30.4M, inclusive of all options, to design and build the world’s largest spindle-coupled road simulator for the U.S. Army. The contract will be... Read more
Basel, 26 July 2019 CHMP recommends EU approval of Roche’s Tecentriq in combination with chemotherapy as an initial treatment of adults with extensive-stage small cell lung cancer Decision based on results from first Phase III study to show a cancer immunotherapy-based combination significantly improved overall survival (OS) and progression-free survival (PFS) in over 20 years... Read more
BILLERICA, Mass., July 17, 2019 /PRNewswire/ — Bruker Corporation (Nasdaq: BRKR) has been advised that former board member, Mr. Joerg C. Laukien, has authorized a block sale of Bruker shares as part of his retirement planning and portfolio diversification. Joerg Laukien retired from the Bruker board of directors effective November 5, 2018. He is the... Read more